AptarGroup, Inc. (NYSE: ATR) director Julie Xing awarded 151 shares

Q: What insider transaction did AptarGroup (ATR) report for director Julie Xing?

AptarGroup reported that director Julie Xing received a grant of 151 shares of Common Stock on 2026-07-16 . This was filed as a grant, award, or other acquisition, not as an open-market purchase or sale.

Q: How many AptarGroup (ATR) shares were granted to Julie Xing and at what price?

Julie Xing was granted 151 shares of AptarGroup Common Stock at a reported price of $0.00 per share . This reflects a compensation-related grant or award rather than a cash purchase in the market.

Q: What are Julie Xing’s AptarGroup (ATR) holdings after the reported grant?

After the reported grant, Julie Xing directly holds 5,242 shares of AptarGroup Common Stock. This total includes the newly awarded 151 shares and represents her direct ownership position following the transaction.

Q: Was the AptarGroup (ATR) Form 4 transaction reported under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox was not marked , indicating the transaction was not reported as made under a pre-arranged 10b5-1 trading plan. No footnotes provide additional 10b5-1 plan details.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Xing Julie reported acquisition or exercise transactions in this Form 4 filing.

Director Julie Xing of AptarGroup, Inc. reported receiving a grant of 151 shares of Common Stock on 2026-07-16 at $0.00 per share. Following this award, she directly owns 5,242 shares of AptarGroup Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Xing Julie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	151	$0.00	--

Holdings After Transaction: Common Stock — 5,242 shares (Direct)

Footnotes (1)

Key Figures

Shares granted: 151 shares Grant price per share: $0.00 Shares owned after transaction: 5,242 shares +1 more

4 metrics

Shares granted 151 shares Common Stock grant reported on 2026-07-16

Grant price per share $0.00 Grant, award, or other acquisition with no cash consideration

Shares owned after transaction 5,242 shares Direct holdings following the reported grant

Transaction date 2026-07-16 Date of reported Common Stock grant to director Julie Xing

Key Terms

Form 4, Grant, award, or other acquisition, Rule 10b5-1, Common Stock

4 terms

Form 4 regulatory

"reported this transaction on Form 4 as an insider filing"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Grant, award, or other acquisition financial

"coded as a Grant, award, or other acquisition of Common Stock"

Rule 10b5-1 regulatory

"The filing’s Rule 10b5-1 checkbox was not marked"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Common Stock financial

"a grant of 151 shares of Common Stock on 2026-07-16"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 02:35 PM Accepted by SEC EDGAR 07/17/2026 - 02:34 PM

FAQ

What insider transaction did AptarGroup (ATR) report for director Julie Xing?

AptarGroup reported that director Julie Xing received a grant of 151 shares of Common Stock on 2026-07-16. This was filed as a grant, award, or other acquisition, not as an open-market purchase or sale.

How many AptarGroup (ATR) shares were granted to Julie Xing and at what price?

Julie Xing was granted 151 shares of AptarGroup Common Stock at a reported price of $0.00 per share. This reflects a compensation-related grant or award rather than a cash purchase in the market.

What are Julie Xing’s AptarGroup (ATR) holdings after the reported grant?

After the reported grant, Julie Xing directly holds 5,242 shares of AptarGroup Common Stock. This total includes the newly awarded 151 shares and represents her direct ownership position following the transaction.

Was the AptarGroup (ATR) Form 4 transaction reported under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox was not marked, indicating the transaction was not reported as made under a pre-arranged 10b5-1 trading plan. No footnotes provide additional 10b5-1 plan details.

Does the AptarGroup (ATR) Form 4 for Julie Xing involve any derivative securities?

No derivative securities are reported for Julie Xing in this filing. The transaction covers Common Stock only, and the derivative positions section of the insider data shows no derivative transactions or remaining derivative holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Xing Julie

(Last)

(First)

(Middle)

C/O APTARGROUP, INC.

265 EXCHANGE DRIVE, SUITE 301

(Street)

CRYSTAL LAKE

ILLINOIS

60014

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
APTARGROUP, INC. [ ATR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/16/2026		A		151	A	$0	5,242	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	Julie Xing by Irene Hudson as attorney-in-fact	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR